Back to Directory

Thymosin Alpha-1

Performance & Endurance

An immune-modulating peptide that enhances immune function and has anti-viral and anti-cancer properties.

Key Benefits

  • ✓Enhances immune system function
  • ✓Supports T-cell development
  • ✓Anti-viral properties
  • ✓May support cancer treatment
  • ✓Reduces inflammation
  • ✓Improves vaccine response
  • ✓Supports recovery from illness
  • ✓May enhance athletic recovery

Dosing Information

Dosage Range
1.6-3.2 mg
Frequency
2-3 times per week
Typical Duration
4-12 weeks depending on purpose

Detailed Protocol

Administered via subcutaneous injection, typically in the abdomen. Can be used acutely during illness or chronically for immune support. Best taken in the morning.

About Thymosin Alpha-1

Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide naturally produced by the thymus gland. It plays a crucial role in the development and function of T-cells and the overall immune system. Tα1 has been used clinically in many countries to treat various diseases including chronic hepatitis B and C, cancer, and immunodeficiencies.

Research Notes

Extensive clinical research, particularly in Asia, has demonstrated Thymosin Alpha-1's immunomodulatory effects. Studies show benefits in treating chronic viral infections, enhancing vaccine responses, and supporting cancer treatment outcomes. It has been shown to normalize T-cell function in immunocompromised individuals.

Get Peptide Research Updates

Newsletter signup

Please wait...

Thanks for signing up! You will receive an email to confirm your subscription.

Potential Side Effects

  • •Minimal side effects
  • •Rare: mild injection site reaction
  • •Very rare: transient fever or fatigue

Always consult with a healthcare professional before starting any peptide therapy.